Effect of extracorporeal shock wave lithotripsy on prostate specific antigen.
OBJECTIVE
We evaluated the effects of extracorporeal shock wave lithotripsy (ESWL) of distal ureteral calculi on serum prostate specific antigen (PSA).


METHODS
A total of 29 consecutive men with distal ureteral calculi at a maximum of 25 mm. from the ureteral orifice, and without any history of urinary tract infection, benign prostatio hyperplasia or prostate cancer underwent ESWL with the Dornier MPL 9000 X lithotriptor. The therapeutic focus size was 48 X 7 mm. PSA was measured exactly 5 minutes before ESWL, as well as 120 minutes, 24 hours and 7 days after termination of treatment.


RESULTS
Fragmentation rate was 100% and all patients were stone-free within 1 week of therapy. There was no statistically significant difference between PSA values before and after treatment. Only 15 patients had a slight increase in PSA at 120 minutes after treatment (range 0.01 to 0.41 ng./ml., mean 0.07).


CONCLUSIONS
ESWL can be performed in men at risk for prostate cancer without impairing the predictive value of PSA.
Colombo
T
T
Universitätsklinik für Urologie, Karl-Franzens-Universität Graz, Austria.
Zigeuner
R
R
Altziebler
S
S
Pummer
K
K
Stettner
H
H
Hubmer
G
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008096:Lithotripsy; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D014514:Ureteral Calculi / Q000097:blood* / Q000628:therapy*
D017430:Prostate-Specific Antigen